AusperBio Therapeutics
Updated: September 07, 2026
CEO - Guofeng Cheng
Country: USA | Funding: $357M (+)
Founded: 2019
Website: https://www.ausperbio.com
AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies. Its lead candidate, dubbed AHB-137, is an unconjugated antisense oligonucleotide (ASO) designed to suppress production of viral hepatitis B protein, inhibit viral DNA replication and promote immune reactivation.
Founded: 2019
Website: https://www.ausperbio.com
AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies. Its lead candidate, dubbed AHB-137, is an unconjugated antisense oligonucleotide (ASO) designed to suppress production of viral hepatitis B protein, inhibit viral DNA replication and promote immune reactivation.
